Spinraza RSS feed1440Copyright: (C) European Medicines Agencyen-gbThu, 13 Jul 2017 19:00:33 +0100http://www.ema.europa.euSpinraza RSS feedHuman medicines European Public Assessment Report (EPAR): Spinraza, nusinersen sodium, Revision: 0, Authorisedhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004312/human_med_002119.jsp&mid=WC0b01ac058001d124http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004312/human_med_002119.jsp&mid=WC0b01ac058001d124Wed, 21 Jun 2017 00:00:00 +0100Orphan designation: Antisense oligonucleotide targeted to the SMN2 gene (nusinersen)http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2012/04/human_orphan_001045.jsp&mid=WC0b01ac058001d12bhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2012/04/human_orphan_001045.jsp&mid=WC0b01ac058001d12bWed, 21 Jun 2017 00:00:00 +0100Spinraza : EPAR - Public assessment reporthttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004312/WC500229706.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004312/WC500229706.pdfWed, 21 Jun 2017 00:00:00 +0100Spinraza : EPAR - Product Informationhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004312/WC500229704.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004312/WC500229704.pdfWed, 21 Jun 2017 00:00:00 +0100Spinraza : EPAR - All Authorised presentationshttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004312/WC500229705.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004312/WC500229705.pdfWed, 21 Jun 2017 00:00:00 +0100Spinraza : EPAR - Summary for the publichttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004312/WC500229707.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004312/WC500229707.pdfWed, 21 Jun 2017 00:00:00 +0100CHMP summary of positive opinion for Spinrazahttp://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004312/WC500226191.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004312/WC500226191.pdfFri, 21 Apr 2017 00:00:00 +0100News and Press Releases: First medicine for spinal muscular atrophy http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002735.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002735.jsp&mid=WC0b01ac058004d5c1Fri, 21 Apr 2017 00:00:00 +0100News and Press Releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&mid=WC0b01ac058004d5c1Fri, 21 Apr 2017 00:00:00 +0100